Page 2 - Pasteur Institut News Today

Variants raise Covid-19 questions, concern

Sensorion: A Chardan Top Pick for 2021 Regulatory News: Sensorion (FR0012596468 ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces the US healthcare investment bank Chardan decision to make Sensorion one of its top picks for 2021, calling the company "2021s hidden gem in gene therapy". It raised its target price to €7, following the an...